![Amy Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Peterson
Directeur/Bestuurslid bij
Conquer Cancer Foundation of the American Society of Clinical
Vermogen: 23 M $ op 31-05-2026
Profiel
Amy C.
Peterson is currently Secretary & Director at Conquer Cancer Foundation of the American Society of Clinical.
Formerly, Dr. Peterson was Associate Group Medical Director at Genentech, Inc. from 2005 to 2011, Vice President-Clinical Development at Medivation LLC (California) from 2011 to 2016, Chief Medical Officer-Immuno-Oncology at BeOne Medicines Ltd. from 2016 to 2019, President & Chief Operating Officer at CytomX Therapeutics, Inc. in 2022, and Chief Medical Officer & Executive Vice President at Exelixis, Inc. from 2023 to 2025.
Education includes a doctorate from Thomas Jefferson University and an undergraduate degree from Wesleyan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EXELIXIS, INC. 0,19% | 16-05-2025 | 465.393 ( 0,19% ) | 23 M $ | 31-05-2026 |
Actieve functies van Amy Peterson
| Bedrijven | Functie | Begin |
|---|---|---|
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Directeur/Bestuurslid | - |
Eerdere bekende functies van Amy Peterson
| Bedrijven | Functie | Einde |
|---|---|---|
| EXELIXIS, INC. | Hoofd Techniek/Wetenschap/O&O | 29-08-2025 |
| CYTOMX THERAPEUTICS, INC. | President | 12-09-2022 |
| BEIGENE LTD | Hoofd Techniek/Wetenschap/O&O | 23-01-2019 |
| MEDIVATION INC | Corporate Officer/Principal | 01-07-2016 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Amy Peterson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
